PARP Inhibitors in Prostate Cancer – Recent Updates and Implications for Clinical Practice
This CME-accredited activity, PARP Inhibitors in Prostate Cancer – Recent Updates and Implications for Clinical Practice, is designed to provide expert interpretation of new and emerging data on the treatment of prostate cancer with PARP inhibitors (PARPi) as a single agen
Category
  • GU Cancer
Format
  • Conference / meeting
  • Hybrid
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Nursing Contact Hours
Event date October 29, 2023
2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes- Webcast
This accredited continuing education activity “Webcast 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes”, is recorded from the live webinar held on 10/07/2022- 10/08/22. 
Category
  • Breast Cancer
  • GI Cancers
  • GU Cancer
  • Hematologic Malignancies
  • Lung Cancer
  • Precision Oncology
Format
  • Video
  • Webinar recorded
Credits
  • 6.50 ABIM MOC II
  • 6.50 AMA PRA Category 1 Credit™
  • 6.50 Nursing Contact Hours